The impact of CYP2C9*3 and calumenin genetic polymorphisms on warfarin dose requirements / Rehab Helmy Mohammed Ibrahim ; Supervised Sanaa Omar Asaad , Neguib Zoheir Mostafa , Heba Sherif Kareem
Material type: TextLanguage: English Publication details: Cairo : Rehab Helmy Mohammed Ibrahim , 2012Description: 122 P. : charts ; 25cmOther title:- تأثير التغير الجينى لكل من جين السيتوكروم (٢س٩) و جين الكاليومينين على ضبط جرعة الوارفارين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.Ph.D.2012.Re.I (Browse shelf(Opens below)) | Not for loan | 01010110057539000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.Ph.D.2012.Re.I (Browse shelf(Opens below)) | 57539.CD | Not for loan | 01020110057539000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
Warfarin is one of the most widely used coumarin anticoagulants. However, its use is made difficult by the wide interindividual variation in dose required to achieve a therapeutic effect, the narrow therapeutic range, and the risk of serious bleeding. Warfarin dose requirement, which varies 20-fold, is influenced by factors such as intake of vitamin K, ethnicity, illness, age, gender, concurrent medication, body mass index and genetic factors
Issued also as CD
There are no comments on this title.